To learn more about NSAIDs and why low-dose NSAIDs are an important new development in treating mild to moderate acute pain and OA pain, click these links: ZORVOLEX® is the first US Food and Drug Administration (FDA) – approved low-dose SoluMatrix® diclofenac for mild to moderate acute pain and OA pain. Iroko Pharmaceuticals, LLC, created ZORVOLEX® with appropriate patients in mind: